HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Supplement GMP Crosshairs More Frequently On Smaller Firms

This article was originally published in The Rose Sheet

Executive Summary

GMP violation warnings to three small dietary supplement firms in late March reflect a “thoughtful shift” by FDA toward inspections of smaller firms, says UNPA President Loren Israelsen. With the supplement GMP final rule past its 10-year anniversary, firms should be meeting their requirements.

You may also be interested in...



Making Enzymes, Cosmetics In A Kitchen And Cataloging Disease Claims Attract FDA Warnings

FDA Office of Regulatory Affairs warned Nature Essence Small Molecule Co. in Lexington, KY, and Warner Herb Co. in Crossville, TN, both single-facility businesses. They likely appeared on FDA radar as it moves from inspecting larger supplement manufacturers for compliance with the 2007 GMP final rule to also reaching small firms.

Opposite Sides Of GMP Coin: Contract Manufacturer, Own-Labeler Warned

Contract manufacturer Nutritional Engineering was warned on Sept. 29, 2017, about GMP violations and misbranding problems found during an inspection in April and May. Liberty, Texas, own-labeler Carol Bond Health Foods was warned March 9 following a September inspection of its facility and a November review of its website.

FDA Publishes Small Entity Guide For Supplement GMPs

FDA publishes good manufacturing practices guidance for small businesses making dietary supplements nearly six months after the deadline for compliance with the GMP final rule.

Related Content

Topics

UsernamePublicRestriction

Register

RS121563

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel